Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1114

1.

Inducible Nitric Oxide Synthase and CD11b+Gr1+ Cells Impair Lymphatic Contraction of Tumor-Draining Lymphatic Vessels.

Liao S, Bouta EM, Morris LM, Jones D, Jain RK, Padera TP.

Lymphat Res Biol. 2018 Oct 24. doi: 10.1089/lrb.2018.0013. [Epub ahead of print]

PMID:
30358484
2.

Publisher Correction: Engineering and physical sciences in oncology: challenges and opportunities.

Mitchell MJ, Jain RK, Langer R.

Nat Rev Cancer. 2018 Nov;18(11):720. doi: 10.1038/s41568-018-0072-x.

PMID:
30337715
3.

Cochlear Proteins Associated with Noise-induced Hearing Loss: An Update.

Jain RK, Pingle SK, Tumane RG, Thakkar LR, Jawade AA, Barapatre A, Trivedi M.

Indian J Occup Environ Med. 2018 May-Aug;22(2):60-73. doi: 10.4103/ijoem.IJOEM_43_18. Review.

4.

A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma.

Goyal L, Zheng H, Abrams TA, Miksad R, Bullock AJ, Allen JN, Yurgelun MB, Clark JW, Kambadakone A, Muzikansky A, Knowles M, Galway A, Afflitto AJ, Dinicola CF, Regan E, Hato T, Mamessier E, Shigeta K, Jain RK, Duda DG, Zhu AX.

Clin Cancer Res. 2018 Sep 6. doi: 10.1158/1078-0432.CCR-18-0847. [Epub ahead of print]

PMID:
30190369
5.

A homing system targets therapeutic T cells to brain cancer.

Samaha H, Pignata A, Fousek K, Ren J, Lam FW, Stossi F, Dubrulle J, Salsman VS, Krishnan S, Hong SH, Baker ML, Shree A, Gad AZ, Shum T, Fukumura D, Byrd TT, Mukherjee M, Marrelli SP, Orange JS, Joseph SK, Sorensen PH, Taylor MD, Hegde M, Mamonkin M, Jain RK, El-Naggar S, Ahmed N.

Nature. 2018 Sep;561(7723):331-337. doi: 10.1038/s41586-018-0499-y. Epub 2018 Sep 5.

PMID:
30185905
6.

Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.

Arvanitis CD, Askoxylakis V, Guo Y, Datta M, Kloepper J, Ferraro GB, Bernabeu MO, Fukumura D, McDannold N, Jain RK.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8717-E8726. doi: 10.1073/pnas.1807105115. Epub 2018 Aug 27.

PMID:
30150398
7.
8.

Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma.

Lee EQ, Duda DG, Muzikansky A, Gerstner ER, Kuhn JG, Reardon DA, Nayak L, Norden AD, Doherty L, LaFrankie D, Stefanik J, Vardam T, Smith KH, McCluskey C, Gaffey S, Batchelor TT, Jain RK, Wen PY.

Clin Cancer Res. 2018 Oct 1;24(19):4643-4649. doi: 10.1158/1078-0432.CCR-18-1025. Epub 2018 Jun 25.

PMID:
29941486
9.

Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer.

Grassberger C, Hong TS, Hato T, Yeap BY, Wo JY, Tracy M, Bortfeld T, Wolfgang JA, Eyler CE, Goyal L, Clark JW, Crane CH, Koay EJ, Cobbold M, DeLaney TF, Jain RK, Zhu AX, Duda DG.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1222-1225. doi: 10.1016/j.ijrobp.2018.04.026. Epub 2018 Apr 17.

PMID:
29859792
10.

Association of trabecular bone score (TBS) and prior fracture differs among minorities in NHANES 2005-2008.

Jain RK, Vokes T.

Osteoporos Int. 2018 Sep;29(9):2093-2099. doi: 10.1007/s00198-018-4584-8. Epub 2018 Jun 1.

PMID:
29858633
11.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 May 15. doi: 10.1007/s10456-018-9613-x. [Epub ahead of print] Review.

12.

Understanding the tumor immune microenvironment (TIME) for effective therapy.

Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, Woodhouse EC, Weinberg RA, Krummel MF.

Nat Med. 2018 May;24(5):541-550. doi: 10.1038/s41591-018-0014-x. Epub 2018 Apr 23. Review.

13.

A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.

Griveau A, Seano G, Shelton SJ, Kupp R, Jahangiri A, Obernier K, Krishnan S, Lindberg OR, Yuen TJ, Tien AC, Sabo JK, Wang N, Chen I, Kloepper J, Larrouquere L, Ghosh M, Tirosh I, Huillard E, Alvarez-Buylla A, Oldham MC, Persson AI, Weiss WA, Batchelor TT, Stemmer-Rachamimov A, Suvà ML, Phillips JJ, Aghi MK, Mehta S, Jain RK, Rowitch DH.

Cancer Cell. 2018 May 14;33(5):874-889.e7. doi: 10.1016/j.ccell.2018.03.020. Epub 2018 Apr 19.

14.

Taxonomy of the family Arenaviridae and the order Bunyavirales: update 2018.

Maes P, Alkhovsky SV, Bào Y, Beer M, Birkhead M, Briese T, Buchmeier MJ, Calisher CH, Charrel RN, Choi IR, Clegg CS, de la Torre JC, Delwart E, DeRisi JL, Di Bello PL, Di Serio F, Digiaro M, Dolja VV, Drosten C, Druciarek TZ, Du J, Ebihara H, Elbeaino T, Gergerich RC, Gillis AN, Gonzalez JJ, Haenni AL, Hepojoki J, Hetzel U, Hồ T, Hóng N, Jain RK, Jansen van Vuren P, Jin Q, Jonson MG, Junglen S, Keller KE, Kemp A, Kipar A, Kondov NO, Koonin EV, Kormelink R, Korzyukov Y, Krupovic M, Lambert AJ, Laney AG, LeBreton M, Lukashevich IS, Marklewitz M, Markotter W, Martelli GP, Martin RR, Mielke-Ehret N, Mühlbach HP, Navarro B, Ng TFF, Nunes MRT, Palacios G, Pawęska JT, Peters CJ, Plyusnin A, Radoshitzky SR, Romanowski V, Salmenperä P, Salvato MS, Sanfaçon H, Sasaya T, Schmaljohn C, Schneider BS, Shirako Y, Siddell S, Sironen TA, Stenglein MD, Storm N, Sudini H, Tesh RB, Tzanetakis IE, Uppala M, Vapalahti O, Vasilakis N, Walker PJ, Wáng G, Wáng L, Wáng Y, Wèi T, Wiley MR, Wolf YI, Wolfe ND, Wú Z, Xú W, Yang L, Yāng Z, Yeh SD, Zhāng YZ, Zhèng Y, Zhou X, Zhū C, Zirkel F, Kuhn JH.

Arch Virol. 2018 Aug;163(8):2295-2310. doi: 10.1007/s00705-018-3843-5. Epub 2018 Apr 21.

PMID:
29680923
15.

Quantifying solid stress and elastic energy from excised or in situ tumors.

Nia HT, Datta M, Seano G, Huang P, Munn LL, Jain RK.

Nat Protoc. 2018 May;13(5):1091-1105. doi: 10.1038/nprot.2018.020. Epub 2018 Apr 19.

PMID:
29674756
16.

Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green.

Carr JA, Franke D, Caram JR, Perkinson CF, Saif M, Askoxylakis V, Datta M, Fukumura D, Jain RK, Bawendi MG, Bruns OT.

Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4465-4470. doi: 10.1073/pnas.1718917115. Epub 2018 Apr 6.

17.

Renin-Angiotensin System Inhibitors to Mitigate Cancer Treatment-Related Adverse Events.

Pinter M, Kwanten WJ, Jain RK.

Clin Cancer Res. 2018 Aug 15;24(16):3803-3812. doi: 10.1158/1078-0432.CCR-18-0236. Epub 2018 Apr 2. Review.

PMID:
29610292
18.

Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.

Stylianopoulos T, Munn LL, Jain RK.

Trends Cancer. 2018 Apr;4(4):292-319. doi: 10.1016/j.trecan.2018.02.005. Epub 2018 Mar 13. Review.

PMID:
29606314
19.

Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy.

Stylianopoulos T, Munn LL, Jain RK.

Trends Cancer. 2018 Apr;4(4):258-259. doi: 10.1016/j.trecan.2018.02.010. Epub 2018 Mar 17.

20.

A Physical View of Cancer.

Jain RK, Batista A.

Trends Cancer. 2018 Apr;4(4):257. doi: 10.1016/j.trecan.2018.03.001. Epub 2018 Mar 16. No abstract available.

PMID:
29606305
21.

Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2.

Incio J, Ligibel JA, McManus DT, Suboj P, Jung K, Kawaguchi K, Pinter M, Babykutty S, Chin SM, Vardam TD, Huang Y, Rahbari NN, Roberge S, Wang D, Gomes-Santos IL, Puchner SB, Schlett CL, Hoffmman U, Ancukiewicz M, Tolaney SM, Krop IE, Duda DG, Boucher Y, Fukumura D, Jain RK.

Sci Transl Med. 2018 Mar 14;10(432). pii: eaag0945. doi: 10.1126/scitranslmed.aag0945.

22.

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.

Fukumura D, Kloepper J, Amoozgar Z, Duda DG, Jain RK.

Nat Rev Clin Oncol. 2018 May;15(5):325-340. doi: 10.1038/nrclinonc.2018.29. Epub 2018 Mar 6. Review.

23.

Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity.

Dixon KO, Schorer M, Nevin J, Etminan Y, Amoozgar Z, Kondo T, Kurtulus S, Kassam N, Sobel RA, Fukumura D, Jain RK, Anderson AC, Kuchroo VK, Joller N.

J Immunol. 2018 Apr 15;200(8):3000-3007. doi: 10.4049/jimmunol.1700407. Epub 2018 Mar 2.

PMID:
29500245
24.

Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.

Zhao Y, Liu P, Zhang N, Chen J, Landegger LD, Wu L, Zhao F, Zhao Y, Zhang Y, Zhang J, Fujita T, Stemmer-Rachamimov A, Ferraro GB, Liu H, Muzikansky A, Plotkin SR, Stankovic KM, Jain RK, Xu L.

Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2077-E2084. doi: 10.1073/pnas.1719966115. Epub 2018 Feb 9.

25.

Solitary Head and Neck Cysticercosis: A Series of Rare Cases.

Chakraborty P, Kumari R, Jain RK, Prasad V, Pradhan S, Joshi P.

Iran J Otorhinolaryngol. 2017 Nov;29(95):347-351.

26.

Development of Software for Automatic Analysis of Intervention in the Field of Homeopathy.

Jain RK, Goyal S, Bhat SN, Rao S, Sakthidharan V, Kumar P, Sajan KR, Jindal SK, Jindal GD.

J Altern Complement Med. 2018 May;24(5):422-430. doi: 10.1089/acm.2017.0157. Epub 2018 Jan 22.

PMID:
29356554
27.

Pharmacological Reperfusion Therapy with Tenecteplase in 7,668 Indian Patients with ST Elevation Myocardial Infarction - A Real World Indian Experience.

Iyengar SS, Nair T, Hiremath J, Dutta AL, Jadhav U, Katyal VK, Kumbla D, Sathyamurthy I, Jain RK, Srinivasan M, Sahoo PK.

J Assoc Physicians India. 2017 Sep;65(9):43-47.

PMID:
29313576
28.

Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers.

Kozin SV, Maimon N, Wang R, Gupta N, Munn L, Jain RK, Garkavtsev I.

Oncotarget. 2017 Nov 26;8(65):108292-108302. doi: 10.18632/oncotarget.22660. eCollection 2017 Dec 12.

29.

Field-usable lateral flow immunoassay for the rapid detection of a macluravirus, large cardamom chirke virus.

Maheshwari Y, Vijayanandraj S, Jain RK, Mandal B.

J Virol Methods. 2018 Mar;253:43-48. doi: 10.1016/j.jviromet.2017.12.009. Epub 2017 Dec 28. Review.

PMID:
29288675
30.

Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.

Reardon DA, Lassman AB, Schiff D, Yunus SA, Gerstner ER, Cloughesy TF, Lee EQ, Gaffey SC, Barrs J, Bruno J, Muzikansky A, Duda DG, Jain RK, Wen PY.

Cancer. 2018 Apr 1;124(7):1438-1448. doi: 10.1002/cncr.31172. Epub 2017 Dec 19.

PMID:
29266174
31.

The Prediction of Body Composition in African Americans From Spine and Hip Dual-Energy Absorptiometry.

Jain RK, Vokes T.

J Clin Densitom. 2017 Oct 25. pii: S1094-6950(17)30157-9. doi: 10.1016/j.jocd.2017.10.040. [Epub ahead of print]

PMID:
29173816
32.

Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma.

Pinter M, Weinmann A, Wörns MA, Hucke F, Bota S, Marquardt JU, Duda DG, Jain RK, Galle PR, Trauner M, Peck-Radosavljevic M, Sieghart W.

United European Gastroenterol J. 2017 Nov;5(7):987-996. doi: 10.1177/2050640617695698. Epub 2017 Feb 26.

33.

Wide-field three-photon excitation in biological samples.

Rowlands CJ, Park D, Bruns OT, Piatkevich KD, Fukumura D, Jain RK, Bawendi MG, Boyden ES, So PT.

Light Sci Appl. 2017 May 5;6:e16255. doi: 10.1038/lsa.2016.255.

34.

Next-generation in vivo optical imaging with short-wave infrared quantum dots.

Bruns OT, Bischof TS, Harris DK, Franke D, Shi Y, Riedemann L, Bartelt A, Jaworski FB, Carr JA, Rowlands CJ, Wilson MWB, Chen O, Wei H, Hwang GW, Montana DM, Coropceanu I, Achorn OB, Kloepper J, Heeren J, So PTC, Fukumura D, Jensen KF, Jain RK, Bawendi MG.

Nat Biomed Eng. 2017;1. pii: 0056. doi: 10.1038/s41551-017-0056. Epub 2017 Apr 10.

35.

Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior.

Li S, Kumar T P, Joshee S, Kirschstein T, Subburaju S, Khalili JS, Kloepper J, Du C, Elkhal A, Szabó G, Jain RK, Köhling R, Vasudevan A.

Cell Res. 2018 Feb;28(2):221-248. doi: 10.1038/cr.2017.135. Epub 2017 Oct 31.

36.

MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma.

Li W, Liu Y, Yang W, Han X, Li S, Liu H, Gerweck LE, Fukumura D, Loeffler JS, Yang BB, Jain RK, Huang P.

J Neurooncol. 2018 Jan;136(1):63-71. doi: 10.1007/s11060-017-2646-y. Epub 2017 Oct 28.

37.
38.

Engineering and physical sciences in oncology: challenges and opportunities.

Mitchell MJ, Jain RK, Langer R.

Nat Rev Cancer. 2017 Nov;17(11):659-675. doi: 10.1038/nrc.2017.83. Epub 2017 Oct 13. Review. Erratum in: Nat Rev Cancer. 2018 Nov;18(11):720.

39.

A cerebellar window for intravital imaging of normal and disease states in mice.

Askoxylakis V, Badeaux M, Roberge S, Batista A, Kirkpatrick N, Snuderl M, Amoozgar Z, Seano G, Ferraro GB, Chatterjee S, Xu L, Fukumura D, Duda DG, Jain RK.

Nat Protoc. 2017 Nov;12(11):2251-2262. doi: 10.1038/nprot.2017.101. Epub 2017 Oct 5.

40.

Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.

Pinter M, Jain RK.

Sci Transl Med. 2017 Oct 4;9(410). pii: eaan5616. doi: 10.1126/scitranslmed.aan5616. Review.

41.

Anti-VEGF treatment improves neurological function in tumors of the nervous system.

Zhang N, Chen J, Ferraro GB, Wu L, Datta M, Jain RK, Plotkin SR, Stemmer-Rachamimov A, Xu L.

Exp Neurol. 2018 Jan;299(Pt B):326-333. doi: 10.1016/j.expneurol.2017.09.008. Epub 2017 Sep 11. Review.

PMID:
28911884
42.

Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer.

Jung K, Heishi T, Incio J, Huang Y, Beech EY, Pinter M, Ho WW, Kawaguchi K, Rahbari NN, Chung E, Kim JK, Clark JW, Willett CG, Yun SH, Luster AD, Padera TP, Jain RK, Fukumura D.

Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):10455-10460. doi: 10.1073/pnas.1710754114. Epub 2017 Sep 12.

43.

Second-line systemic therapy in metastatic renal-cell carcinoma: A review.

Jain RK, Gandhi S, George S.

Urol Oncol. 2017 Nov;35(11):640-646. doi: 10.1016/j.urolonc.2017.08.010. Epub 2017 Sep 5. Review.

PMID:
28887097
44.

YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis.

Wang X, Freire Valls A, Schermann G, Shen Y, Moya IM, Castro L, Urban S, Solecki GM, Winkler F, Riedemann L, Jain RK, Mazzone M, Schmidt T, Fischer T, Halder G, Ruiz de Almodóvar C.

Dev Cell. 2017 Sep 11;42(5):462-478.e7. doi: 10.1016/j.devcel.2017.08.002. Epub 2017 Aug 31.

45.

Minimally Invasive Plate Osteosynthesis Using Locking Plates for AO 43-Type Fractures: Lessons Learnt From a Prospective Study.

Shukla R, Jain N, Jain RK, Patidar S, Kiyawat V.

Foot Ankle Spec. 2018 Jun;11(3):236-241. doi: 10.1177/1938640017726134. Epub 2017 Aug 17.

PMID:
28814102
46.

A Photoaffinity Labeling-Based Chemoproteomics Strategy for Unbiased Target Deconvolution of Small Molecule Drug Candidates.

Thomas JR, Brittain SM, Lipps J, Llamas L, Jain RK, Schirle M.

Methods Mol Biol. 2017;1647:1-18. doi: 10.1007/978-1-4939-7201-2_1.

PMID:
28808992
47.

Rapid Discharge to Home After Total Knee Arthroplasty Is Safe in Eligible Medicare Patients.

Klingenstein GG, Schoifet SD, Jain RK, Reid JJ, Porat MD, Otegbeye MK.

J Arthroplasty. 2017 Nov;32(11):3308-3313. doi: 10.1016/j.arth.2017.06.034. Epub 2017 Jun 27.

PMID:
28754579
48.

Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors.

Wong ML, Murphy J, Harrington E, Gower CM, Jain RK, Schirle M, Thomas JR.

Proteome Sci. 2017 Jul 17;15:17. doi: 10.1186/s12953-017-0125-1. eCollection 2016.

49.

Dual-energy X-ray Absorptiometry.

Jain RK, Vokes T.

J Clin Densitom. 2017 Jul - Sep;20(3):291-303. doi: 10.1016/j.jocd.2017.06.014. Epub 2017 Jul 14. Review.

PMID:
28716497
50.

Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.

Jung K, Heishi T, Khan OF, Kowalski PS, Incio J, Rahbari NN, Chung E, Clark JW, Willett CG, Luster AD, Yun SH, Langer R, Anderson DG, Padera TP, Jain RK, Fukumura D.

J Clin Invest. 2017 Aug 1;127(8):3039-3051. doi: 10.1172/JCI93182. Epub 2017 Jul 10.

Supplemental Content

Loading ...
Support Center